Clinical studies of oncopreparations. Interview with the MCSC expert.


Employees of MCSC named after A. S. Loginov are actively involved in clinical trials of drugs for the treatment of patients with malignant tumors.

In the new issue of the Moscow Medicine magazine for healthcare professionals in the capital, the Deputy Director of the MCSC for Oncology, Doctor of Medical Sciences, Professor Lyudmila Zhukova answered the questions:

  • What are the advantages of the latest developments in cancer drugs?
  • against what oncological diseases are these drugs effective?
  • what kind of training should a specialist undergo in order to become full-fledged members of a team of clinical researchers?

About this and more - read in the electronic version of the magazine at the link.

#Переведено YandexTranslate
GBUZ Moscow Clinical Scientific Center named after Loginov MHD